- Home
- TVTX vs HASI Comparison
TVTX vs HASI Comparison
Compare TVTX & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- HASI
- Stock Information
- Founded
- TVTX 2008
- HASI 1981
- Country
- TVTX United States
- HASI United States
- Employees
- TVTX N/A
- HASI N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- HASI Real Estate Investment Trusts
- Sector
- TVTX Health Care
- HASI Real Estate
- Exchange
- TVTX Nasdaq
- HASI Nasdaq
- Market Cap
- TVTX 3.1B
- HASI 3.4B
- IPO Year
- TVTX N/A
- HASI 2013
- Fundamental
- Price
- TVTX $35.18
- HASI $33.26
- Analyst Decision
- TVTX Strong Buy
- HASI Strong Buy
- Analyst Count
- TVTX 15
- HASI 6
- Target Price
- TVTX $37.21
- HASI $38.83
- AVG Volume (30 Days)
- TVTX 2.1M
- HASI 1.4M
- Earning Date
- TVTX 10-30-2025
- HASI 11-06-2025
- Dividend Yield
- TVTX N/A
- HASI 5.09%
- EPS Growth
- TVTX N/A
- HASI 27.54
- EPS
- TVTX N/A
- HASI 2.32
- Revenue
- TVTX $435,826,000.00
- HASI $99,644,000.00
- Revenue This Year
- TVTX $108.68
- HASI $184.74
- Revenue Next Year
- TVTX $40.23
- HASI $13.79
- P/E Ratio
- TVTX N/A
- HASI $14.25
- Revenue Growth
- TVTX 114.22
- HASI N/A
- 52 Week Low
- TVTX $12.91
- HASI $21.98
- 52 Week High
- TVTX $36.76
- HASI $34.28
- Technical
- Relative Strength Index (RSI)
- TVTX 66.12
- HASI 66.09
- Support Level
- TVTX $33.05
- HASI $32.30
- Resistance Level
- TVTX $36.76
- HASI $34.28
- Average True Range (ATR)
- TVTX 1.95
- HASI 1.13
- MACD
- TVTX -0.02
- HASI 0.50
- Stochastic Oscillator
- TVTX 80.99
- HASI 86.14
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.